Quality of reporting in studies on bipolar disorders. Implications for the development of guidelines;"Quality of reporting" in studien zur bipolaren störung: Folgen für die leitlinienentwicklung

Nervenarzt

Volumn 83, Issue 5, 2012, Pages 604-617

  Soltmann, B ^a,b   Pfennig, A ^a   Weikert, B ^a,c   Bauer, M ^a   Strech, D ^d  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c ÄZQ   (Germany)

^d CELLS Centre for Ethics and Law in the Life Sciences   (Germany)

Author keywords

Bipolar disorder; CONSORT statement; Guidelines; Psychiatry; Quality of reporting

Indexed keywords

ARTICLE; BIPOLAR DISORDER; HUMAN; INFORMATION PROCESSING; LIBRARY SCIENCE; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCIENTIFIC LITERATURE; SYSTEMATIC REVIEW;

BIPOLAR DISORDER; DOCUMENTATION; EVIDENCE-BASED MEDICINE; GERMANY; HUMANS; PRACTICE GUIDELINES AS TOPIC; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY;

EID: 84863114432     PISSN: 00282804     EISSN: 14330407     Source Type: Journal    
DOI: 10.1007/s00115-011-3418-0     Document Type: Article

References (31)

1. Altman DG (1996) Better reporting of randomised controlled trials: the CONSORT statement. BMJ 313:570-571 (Pubitemid 26293636)
2. Atkins D, Best D, Briss PA et al (2004) Grading quality of evidence and strength of recommendations. BMJ 328:1490
3. Augestad KM, Berntsen G, Lassen K et al (2011) Standards for reporting randomized controlled trials in medical informatics: a systematic review of CONSORT adherence in RCTs on clinical decision support. J Am Med Inform Assoc 19:13-21
4. Bai Y, Gao J, Zou D et al (2009) Methodological reporting of randomized clinical trials in major gastroenterology and hepatology journals in 2006. Hepatology 49:2108-2112
5. Chan A, Hróbjartsson A, Haahr MT et al (2004) Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 291:2457-2465 (Pubitemid 38669189)
6. Cipriani A, Malvini L, Furukawa TA et al (2007) Relationship between quality of reports of antidepressant randomized controlled trials and treatment estimates: systematic review, meta-analysis, and meta-regression analysis. J Clin Psychopharmacol 27:352-356 (Pubitemid 47075505)
7. Dwan K, Altman DG, Arnaiz JA et al (2008) Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One 3:e3081
8. Dwan K, Gamble C, Williamson PR et al (2008) Reporting of clinical trials: a review of research funders' guidelines. Trials 9:66
9. Emanuel EJ, Wendler D, Grady C (o J) What makes clinical research ethical? JAMA 283:2701-2711
10. Falagas ME, Grigori T, Ioannidou E (2009) A systematic review of trends in the methodological quality of randomized controlled trials in various research fields. J Clin Epidemiol 62:227-231
11. Han C, Kwak K, Marks DM et al (2009) The impact of the CONSORT statement on reporting of randomized clinical trials in psychiatry. Contemp Clin Trials 30:116-122
12. Huwiler-Müntener K, Jüni P, Junker C et al (2002) Quality of reporting of randomized trials as a measure of methodologic quality. JAMA 287:2801-2804 (Pubitemid 34591968)
13. IQWIG Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (2011) Allgemeine Methoden Version 4.0. Köln
14. Jadad AR, Moore RA, Carroll D et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1-12 (Pubitemid 26120810)
15. Jüni P, Altman DG, Egger M (2001) Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 323:42-46 (Pubitemid 32682008)
16. Moher D, Schulz KF, Altman DG (2001) The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357:1191-1194 (Pubitemid 32378696)
17. National Institute for Health and Clinical Excellence (2006) Bipolar Disorder. The management of Bipolar disorder in adults, children and adolescents, in primary and secondary care. National clinical practice guideline number 38. The British psychological society and gaskell, London, England
18. Pfennig A, Kopp I, Strech D et al (2010) Das Konzept der Entwicklung von S3-Leitlinien. Nervenarzt 81:1079-1084
19. Pfennig A, Weikert B, Falkai P et al (2008) Entwicklung der evidenzbasierten S3-Leitlinie zur Diagnostik und Therapie bipolarer Störungen. Ein Kooperationsprojekt der Deutschen Gesellschaft für Bipolare Störungen e. V. (DGBS) und der Deutschen Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde (DGPPN). Nervenarzt 79:500-506
20. Sackett DL (2000) Evidence-based medicine. How to practice and teach EBM, 2. Aufl. Churchill Livingstone, Edinburgh, New York
21. Schulz KF, Altman DG, Moher D (2010) CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med 152:726-732
22. Schulz KF, Chalmers I, Hayes RJ et al (1995) Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273:408-412
23. Simera I, Moher D, Hoey J et al (2010) A catalogue of reporting guidelines for health research. Eur J Clin Invest 40:35-53
24. Song F, Parekh S, Hooper L et al (2010) Dissemination and publication of research findings: an updated review of related biases. Health Technol Assess 14: iii, ix-xi, 1-193
25. Strech D (2012) Normative arguments and new solutions for the unbiased registration and publication of clinical trials. J Clin Epidemiol 65:276-281
26. Strech D, Soltmann B, Weikert B et al (2011) Quality of reporting of randomized controlled trials of pharmacologic treatment of bipolar disorders: a systematic review. J Clin Psychiatry 72:1214-1221
27. Thornley B, Adams C (1998) Content and quality of 2000 controlled trials in schizophrenia over 50 years. BMJ 317:1181-1184 (Pubitemid 28488506)
28. Turner EH, Matthews AM, Linardatos E et al (2008) Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 358:252-260
29. Whittington CJ, Kendall T, Fonagy P et al (2004) Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 363:1341-1345 (Pubitemid 38529872)
30. Wieseler B, McGauran N, Kaiser T (2010) Finding studies on reboxetine: a tale of hide and seek. BMJ 341:c4942
31. Ziogas DC, Zintzaras E (2009) Analysis of the quality of reporting of randomized controlled trials in acute and chronic myeloid leukemia, and myelodysplastic syndromes as governed by the CONSORT statement. Ann Epidemiol 19:494-500